Research graph
References from Contrast clearance analysis in post-operative brain metastases resection cavities: case series and literature review. Local targets link to admitted publications; unresolved targets remain external evidence.
EANO-ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours
10.1016/j.annonc.2021.07.016 · 2021 · External reference
Time window for postoperative reactive enhancement after resection of brain tumors: less than 72 hours
10.3171/2014.9.focus14479 · 2014 · External reference
Tumor bed dynamics after surgical resection of brain metastases: implications for postoperative radiosurgery
10.1016/j.ijrobp.2012.01.067 · 2012 · External reference
Radionecrosis after stereotactic radiotherapy for brain metastases
10.1080/14737175.2016.1184572 · 2016 · External reference
Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis
10.1186/1748-717x-6-48 · 2021 · External reference
Single- and multifraction stereotactic radiosurgery dose/volume tolerances of the brain
10.1016/j.ijrobp.2020.08.013 · 2021 · External reference
Hypofractionated stereotactic radiotherapy for large brain metastases: optimizing the dosimetric parameters
10.1016/j.canrad.2020.04.011 · 2021 · External reference
Multi-institutional analysis of prognostic factors and outcomes after hypofractionated stereotactic radiotherapy to the resection cavity in patients with brain metastases
10.1001/jamaoncol.2020.4630 · 2020 · External reference
Complete resection of brain metastases – when does it matter
10.1007/s11060-025-05193-9 · 2025 · External reference
Postoperative absence of residual intracranial tumor volume is associated with improved survival and intracranial disease control in non-small cell lung cancer brain metastases
10.1007/s11060-025-05387-1 · 2026 · External reference
Stereotactic radiosurgery for postoperative metastatic surgical cavities: a critical review and international stereotactic radiosurgery society (ISRS) practice guidelines
10.1016/j.ijrobp.2021.04.016 · 2021 · External reference
Postoperative management of recurrence after radiosurgery and surgical resection for brain metastases and predicting benefit from adjuvant radiation
10.1016/j.prro.2023.05.010 · 2023 · External reference
Patterns of recurrence after postoperative stereotactic radiotherapy for brain metastases
10.3390/cancers17091557 · 2025 · External reference
Advanced magnetic resonance imaging in the evaluation of treated glioblastoma: a pictorial essay
10.3390/cancers15153790 · 2023 · External reference
The use of treatment response assessment maps in discriminating between radiation effect and persistent tumoral lesion in metastatic brain tumors treated with gamma knife radiosurgery
10.1016/j.wneu.2020.11.114 · 2021 · External reference
MRI-based contrast clearance analysis shows high differentiation accuracy between radiation-induced reactions and progressive disease after cranial radiotherapy
10.1016/j.esmoop.2022.100424 · 2022 · External reference
Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: a report of the PET/RANO group
10.1093/neuonc/noae049 · 2024 · External reference
Delayed contrast extravasation MRI: a new paradigm in neuro-oncology
10.1093/neuonc/nou230 · 2015 · External reference
Contrast clearance analysis (CCA) to assess viable tumor following stereotactic radiosurgery for NSCLC brain metastasis
10.3390/cancers16061218 · 2024 · External reference
Evaluating the diagnostic ability of treatment response assessment maps (TRAMs)/contrast clearance analysis (CCA) in predicting the presence of active brain tumors
10.1177/19714009251324305 · 2025 · External reference
Response assessment of GBM during immunotherapy by delayed contrast treatment response assessment maps
10.3389/fneur.2024.1374737 · 2024 · External reference
Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial
10.1016/s1470-2045(17)30414-x · 2017 · External reference
RANO 2.0: update to the response assessment in neuro-oncology criteria for high- and low-grade gliomas in adults
10.1200/jco.23.01059 · 2023 · External reference
